Tip sheet for the November 25, 2003 Neurology journal

November 24, 2003

Coming in the November 25, 2003 Neurology Journal

RNA ("ribonucleomics") gene slicing reveals mutations in McArdle patients
The Human Genome Project confirmed that one gene controls many proteins. New types of mutations are being revealed, and this study looks at McArdle's disease, an inherited disease in which abnormal amounts of glycogen accumulate in skeletal muscle resulting in weakness and cramping. An accompanying editorial "Echo of silence: Silent mutations, RNA splicing and neuromuscular diseases" makes the science of this paper understandable.

Levodopa addiction in nonparkinsonian patients
Patients with Parkinson's disease (PD) often crave their next dose of levodopa. This craving has been attributed to the severity of PD symptoms with loss of levodopa benefit. The study observed psychological and physiological symptoms - signs of addiction and withdrawal - in five people without PD who were weaned off levodopa. This suggests that levodopa can be very addictive, and could explain PD patients' impatience with waiting for their next dose.

A "Patient Page" article on Myasthenia Gravis and pregnancy will be available for download at www.Neurology.org on November 25, or can be obtained in advance from AAN Media Relations staff.

Upcoming Events

Advances in Neurology media briefing
The American Medical Association is sponsoring a media briefing on breaking news from Neurology, the scientific journal of the American Academy of Neurology, and the Journal of Neuropsychiatry and Clinical Neuroscience on Thursday, December 4, 2003, from 9:00 a.m. to 2:00 p.m., at the Millennium Broadway Hotel in New York. Researchers from major academic and scientific institutions will present. Timothy Pedley, MD, Neurological Institute, New York, AAN board member and former chair of the AAN Science Committee, will moderate. Contact Lise Steves, AMA PIO with Science News, 312-464-5926, or Lise_Stevens@ama-assn.org.

AAN supports public forum on "Exploring Environmental Links to Disease: A Look at Parkinson's Disease and Non-Hodgkin's Lymphoma," on December 4 - 5, in Sioux Falls, South Dakota. Sponsored by the Institute for Agriculture and Trade Policy, the conference is intended to raise awareness, particularly in rural communities, of possible links between environmental exposure to chemicals and chronic diseases such as Parkinson's disease and non-Hodgkin's lymphoma. The program features national experts. Questions regarding the conference can be addressed to Lesley White, IATP, 612-870-3466, or lwhite@iatp.org.
-end-
For more information about the American Academy of Neurology, visit its web site at www.aan.com.

American Academy of Neurology

Related Lymphoma Articles from Brightsurf:

Oncotarget: An integrative microenvironment approach for follicular lymphoma
Oncotarget Volume 11, Issue 33 features Figure 8, ''Haplotype estimates in follicular lymphoma patients,'' by Assis-Mendonça, et al. which reported that the authors tested associations between SNPs, clinicopathological features and TME composition, and proposed survival models in R-CHOP/R-CVP-treated patients.

Novel Radioimmunotherapy Reverses Resistance to Commonly Used Lymphoma Drug
A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.

A new immunotherapeutic agent for children and adolescents with advanced lymphoma
The excellent results of the phase III international paediatric study, Inter-B-NHL ritux 2010, have been published in the New England Journal of Medicine.

Lymphoma's different route revealed
Researchers at the MDC observe the very early stages of blood vessel development in lymph node tumors.

Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba have shown by in vivo experimentation on a mouse model that angioimmunoblastic T-cell lymphoma is highly dependent on T-Cell Receptor Signaling.

Suspect eliminated as a therapeutic target in B cell lymphoma
Australian researchers have narrowed the focus on which survival proteins are important for the survival of B cell lymphomas, eliminating the protein BCL-W from the 'suspect list'.

New factor in the development of childhood lymphoma
The immune system is highly complex and a detailed understanding of many underlying mechanisms is still lacking.

Antibiotics can inhibit skin lymphoma
New research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibiotics inhibit cancer in the skin in patients with rare type of lymphoma.

Association of BRCA2 mutations with risk of childhood lymphoma
This research letter reports on the association of BRCA2 gene mutations and potential risk for pediatric or adolescent lymphoma.

Why Hodgkin's lymphoma cells grow uncontrollably
Although classical Hodgkin's lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery.

Read More: Lymphoma News and Lymphoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.